Inventor · disambiguated record
Sayan Mondal
Also filed as: Mondal Sayan
24 granted patents·11 pending applications·81 citations·filing 2016–2025
95Inventor score
Files withNIMBUS LAKSHMI INC19AJAX THERAPEUTICS INC7SCHROEDINGER INC5SCHROEDINGER LLC2TAKEDA PHARMACEUTICALS CO2
Top patents by PatentIndex Score
35 records- 0197US10023571B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2016·Granted Jul 17, 2018·15 cites·17 claims
- 0296US11220508B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2020·Granted Jan 11, 2022·8 cites·20 claims
- 0394US10323036B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2017·Granted Jun 18, 2019·8 cites·12 claims
- 0493US10562907B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2019·Granted Feb 18, 2020·4 cites·26 claims
- 0592US11691963B26-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitorsAJAX THERAPEUTICS INC·Filed 2021·Granted Jul 4, 2023·5 cites·30 claims
- 0691US11046698B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2018·Granted Jun 29, 2021·6 cites·12 claims
- 0791US10793574B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2019·Granted Oct 6, 2020·8 cites·12 claims
- 0890US10577373B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2019·Granted Mar 3, 2020·5 cites·28 claims
- 0990US10508120B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2019·Granted Dec 17, 2019·5 cites·30 claims
- 1089US10570145B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2019·Granted Feb 25, 2020·4 cites·26 claims
- 1189US10562906B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2019·Granted Feb 18, 2020·4 cites·28 claims
- 1288US10647713B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2017·Granted May 12, 2020·4 cites·12 claims
- 1384US12043632B26-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitorsAJAX THERAPEUTICS INC·Filed 2021·Granted Jul 23, 2024·1 cites·35 claims
- 1484US10781204B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2018·Granted Sep 22, 2020·3 cites·8 claims
- 1581US2023317214A1Methods for predicting an active set of compounds having alternative cores, and drug discovery methods involving the sameSCHROEDINGER INC·Filed 2023·Application pending·0 cites
- 1679US2023056447A1Tyk2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2021·Application pending·0 cites
- 1778US2025326760A1Tyk2 inhibitors and uses thereofTAKEDA PHARMACEUTICALS CO·Filed 2025·Application pending·0 cites
- 1878US2023074228A1Tyk2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2022·Application pending·0 cites
- 1977US2022356184A1Tyk2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2021·Application pending·0 cites
- 2073US2024254125A16-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitorsAJAX THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2172US12221453B2Substituted pyrazolo[5′,1′:2,3]pyrimido[5,4-b][1,4]oxazines as TYK2 inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Feb 11, 2025·0 cites·3 claims
- 2272US2022073527A1Tyk2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2021·Application pending·0 cites
- 2371US11970494B26-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitorsAJAX THERAPEUTICS INC·Filed 2022·Granted Apr 30, 2024·0 cites·30 claims
- 2470US12275717B26-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitorsAJAX THERAPEUTICS INC·Filed 2023·Granted Apr 15, 2025·0 cites·29 claims
- 2568US12162881B2Forms and compositions of inhibitors of JAK2AJAX THERAPEUTICS INC·Filed 2022·Granted Dec 10, 2024·0 cites·20 claims
- 2668US11434240B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2020·Granted Sep 6, 2022·0 cites·17 claims
- 2766US10216911B2Physics-based computational methods for predicting compound solubilitySCHROEDINGER LLC·Filed 2016·Granted Feb 26, 2019·1 cites·21 claims
- 2865US2024368157A1Forms and compositions of a jak2 inhibitorAJAX THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2964US11414431B2Substituted pyrazolo[1,5-a]pyrimidines as TYK2 inhibitorsNIMBUS LAKSHMI INC·Filed 2019·Granted Aug 16, 2022·0 cites·9 claims
- 3060US11396508B2TYK2 inhibitors and uses thereofNIMBUS LAKSHMI INC·Filed 2020·Granted Jul 26, 2022·0 cites·20 claims
- 3158US10783985B2Physics-based computational methods for predicting compound solubilitySCHROEDINGER LLC·Filed 2019·Granted Sep 22, 2020·0 cites·21 claims
- 3255US11710543B2Methods for predicting an active set of compounds having alternative cores, and drug discovery methods involving the sameSCHROEDINGER INC·Filed 2018·Granted Jul 25, 2023·0 cites·9 claims
- 3351US2024199634A1Cyclic compounds and methods of using sameSCHROEDINGER INC·Filed 2022·Application pending·0 cites
- 3450US2023365584A1Heterocyclic pericondensed cdc7 kinase inhibitors for the treatment of cancerSCHROEDINGER INC·Filed 2021·Application pending·0 cites
- 3548US2023101747A1Cyclic compounds and methods of using sameSCHROEDINGER INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sayan Mondal files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →